JPS6267027A - Dermal drug for external use - Google Patents
Dermal drug for external useInfo
- Publication number
- JPS6267027A JPS6267027A JP60205999A JP20599985A JPS6267027A JP S6267027 A JPS6267027 A JP S6267027A JP 60205999 A JP60205999 A JP 60205999A JP 20599985 A JP20599985 A JP 20599985A JP S6267027 A JPS6267027 A JP S6267027A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- isodon
- skin
- plant
- external use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明はシソ科ヤマハツカ属植物の抽出物を配合するこ
とにより肌のほてり、肌荒れ、カミソリまけ、炎症、し
もやけ、欝血、脚のむくみ、血管の浮き等を防止する効
果に優れた皮膚外用剤に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention cures hot flashes, rough skin, razor burn, inflammation, chilblains, congestion, swelling of the legs, etc. by blending an extract of a plant of the Lamiaceae family, genus Yamahata. This invention relates to a topical skin preparation that is highly effective in preventing the appearance of blood vessels.
[従来の技術]
従来、天然物から抽出した各種原料、例えばタンパク質
、多糖、抽出エキス、天然高分子等が、その使用効果が
特徴的であるため、皮膚外用剤に配合されてきた。しか
し日焼は後のほてり、カミソリまけ、肌荒れ等を防止す
る効果に優れた皮膚外用剤は待望されているが、いまだ
十分でなかった。[Prior Art] Conventionally, various raw materials extracted from natural products, such as proteins, polysaccharides, extracted extracts, natural polymers, etc., have been incorporated into external skin preparations because of their distinctive effects. However, although there has been a long-awaited development of an external skin preparation that is highly effective in preventing hot flashes, razor burn, rough skin, etc. after sunburn, there has not yet been a sufficient supply of such preparations.
[発明が解決しようとする問題点〕
本発明者らは、上記事情に鑑み、皮膚に特徴的な有用性
を有する天然原料を得るべく鋭意研究を重ねた結果、シ
ソ科ヤマハツカ属植物の抽出物を配合した皮膚外用剤は
、肌のほてり、肌荒れ、カミソリまけ、炎症、しもやけ
、欝血、脚のむくみ、血管の浮き等を防止する効果に優
れている事を見出し、本発明を完成するに至った。[Problems to be Solved by the Invention] In view of the above circumstances, the present inventors have conducted intensive research to obtain natural raw materials that have characteristic usefulness for the skin, and as a result, they have developed an extract of a plant of the genus Yamahata, family Lamiaceae. It was discovered that a skin external preparation containing the following is excellent in preventing hot flashes, rough skin, razor burn, inflammation, chilblains, congestion, swelling of the legs, floating blood vessels, etc., and thus completed the present invention. It's arrived.
[問題点を解決するための手段]
すなわち、本発明はシソ科ヤマハツカ属植物の抽出物を
配合することを特徴とする皮膚外用剤に関する。[Means for Solving the Problems] That is, the present invention relates to a skin preparation for external use, which is characterized by containing an extract of a plant belonging to the Lamiaceae family and genus Yamahatu.
以下本発明の構成について詳述する。The configuration of the present invention will be explained in detail below.
本発明で用いるシソ科ヤマハツカ属植物としては、ヒキ
オコシ、クロバナヒキオコシ、カメバヒキオコシ等が挙
げられる。Examples of the plants of the Lamiaceae genus Yamahata used in the present invention include Hikiokoshi, Kurobana Hikiokoshi, Kamebahikiokoshi, and the like.
本発明で用いるシソ科ヤマハツカ属植物の抽出物の抽出
方法はシソ科ヤマハツカ属植物の葉、茎または全草を溶
媒、例えば、熱水やメタノール、エタノール等の低級ア
ルコールあるいは含水低級アルコールあるいはプロピレ
ングリコール、1−3ブチレングリコール等の多価アル
コールあるいは含水多価アルコール等のアルコール抽出
物またはクロロホルム、酢酸エチルエステル等の有機溶
媒の1種または2種以上と共に加熱還流し濾過しで得ら
れる抽出液を濃縮して得られる。The method for extracting the extract of a plant of the genus Yamahata of the Lamiaceae family used in the present invention is to use a solvent such as hot water, a lower alcohol such as methanol or ethanol, a hydrous lower alcohol, or propylene glycol to , an extract obtained by heating under reflux and filtration with an alcohol extract such as a polyhydric alcohol such as 1-3 butylene glycol or a water-containing polyhydric alcohol, or one or more organic solvents such as chloroform and ethyl acetate. Obtained by concentration.
本発明におけるシソ科ヤマハツカ属植物の抽出物の配合
量は、皮膚外用剤全量中、乾燥物として0.0001〜
10重量%、好ましくは0.001〜5重量%である。In the present invention, the blending amount of the extract of a plant of the genus Yamahata of the family Lamiaceae is from 0.0001 to 0.0001 as a dry matter in the total amount of the skin external preparation.
10% by weight, preferably 0.001-5% by weight.
0.0001重量%以下であると、本発明でいう効果が
十分に発揮きれず、好ましくない。If it is less than 0.0001% by weight, the effect of the present invention cannot be fully exhibited, which is not preferable.
本発明の皮膚外用剤は前記の必須成分に加えて必要に応
じて、本発明の効果を損なわない範囲内で、化粧品、医
薬部外品、医薬品等に一般に用いられる各種成分、すな
わち水性成分、粉末成分、油分、界面活性剤、保湿剤、
増粘剤、防腐剤、酸化防止剤、香料、色剤、薬剤等を配
合することかでざる。また本発明の皮膚外用剤の剤型は
任意であり、例えば化粧水等の可溶化系、乳液、クリー
ム等の乳化系あるいはファンデーション、分散液、軟膏
などの剤型をとることができる。尚、外皮適用による効
果は、血管収縮効果と実使用テストによる皮膚に対する
、肌のほてり、肌荒れ、カミソリまけ、脚のむくみ、血
管の浮き等に対する解消率から判定した。In addition to the above-mentioned essential ingredients, the external skin preparation of the present invention may optionally include various ingredients commonly used in cosmetics, quasi-drugs, pharmaceuticals, etc., i.e., aqueous ingredients, within the range that does not impair the effects of the present invention. Powder ingredients, oil, surfactants, humectants,
This means adding thickeners, preservatives, antioxidants, fragrances, coloring agents, drugs, etc. Moreover, the dosage form of the skin external preparation of the present invention is arbitrary, and can be, for example, a solubilized system such as a lotion, an emulsified system such as a milky lotion or a cream, or a dosage form such as a foundation, a dispersion, or an ointment. The effect of skin application was determined based on the vasoconstriction effect and the rate of relief from hot flashes, rough skin, razor burn, swelling of the legs, floating blood vessels, etc. on the skin in actual use tests.
(血管収縮効果測定方法)
一般にむくみを判定する方法として用いられている血管
収縮試験を行った。家兎の下行大動脈を摘出し、ラセン
状標本を作成する。これを37℃のTyrodet夜(
10+++1)中に懸垂し、ナンブル(0,1m1)滴
下後の等偏性収縮を測定し、医薬品として使われている
N E (Norepinephrine)の2 X
10−8Molのエタノール溶液により惹起される収縮
効果と比較し、その結果を表−1に示した。(Method for measuring vasoconstriction effect) A vasoconstriction test, which is generally used as a method for determining swelling, was conducted. Remove the descending aorta from a domestic rabbit and create a helical specimen. This was carried out on a Tyrodet night at 37°C (
10+++1) and measured the isotropic contraction after dropping Namburu (0.1ml), and measured the 2X of N E (Norepinephrine) used as a pharmaceutical product.
The contraction effect was compared with that induced by a 10-8M ethanol solution, and the results are shown in Table 1.
判定方法を以下に示す。The determination method is shown below.
(V;]定)
0:NEの2 X 10−8Molにより惹起される収
縮に比べ収縮がより大きい。(V; ] constant) 0: The contraction is larger than that induced by 2 x 10-8 Mol of NE.
○° ノ/ n 同程度
△: ノl ツノ 若干弱い
×; ノ/ ツノ 殆ど効果なし表−1より明
らかなようにヒキオコシ抽出物及びクロバナヒキオコシ
抽出物に非常に強い血管収縮効果を認めた。○° ノ/n Same level △: Nol Horn Slightly weak ×; ノ/horn Almost no effect As is clear from Table 1, a very strong vasoconstrictor effect was observed in the Cucumber extract and the Clover extract.
次に実使用テストによる、肌のほてり、肌荒れ、カミソ
リまけ、脚のむくみ、および血管の浮き等の試験を下記
の試験方法で実施した。Next, actual use tests were conducted to check for hot flashes, rough skin, razor burn, leg swelling, and bulging of blood vessels, etc., using the following test methods.
(試験方法)
肌のほてり、肌荒れ、脚のむくみ、血管の浮き等のそれ
ぞれの症状に悩む各試験者各々20人ひ実施し、表−2
より得られるローションを顔面に塗布し、はてり及び1
週間後の肌荒れを判定し、また、脚に表−2より得られ
るローションを塗布し、脚のむくみ、血管の浮きを判定
し総合評価した。また、健康な男性の被試験者20名で
実施し、ひげそり後に、その都度、表−2より得られる
ローションを塗りカミソリまけに対する効果を調べた。(Test method) The test was conducted by 20 testers each suffering from various symptoms such as hot flashes, rough skin, swelling of the legs, and bulging of blood vessels.Table 2
Apply the obtained lotion to the face, apply the lotion and
The roughness of the skin after a week was evaluated, and the lotion obtained from Table 2 was applied to the legs, and the swelling of the legs and the lifting of the blood vessels were evaluated for a comprehensive evaluation. The test was also conducted on 20 healthy male subjects, and each time after shaving, the lotion obtained from Table 2 was applied to examine the effect on shaving.
結果を表−3に示した。The results are shown in Table-3.
判定基準を以下に示す。The judgment criteria are shown below.
(肌のほてり、肌荒れ、脚のむくみ、血管の浮きの判定
基準)
著効:肌のほてり、および1週間後の肌荒れ、脚のむ(
み、血管の浮きがほとん
ど目立たなくなった。(Criteria for determining hot flashes of the skin, rough skin, swelling of the legs, and raised blood vessels) Effectiveness: Hot flashes of the skin, rough skin after one week, swelling of the legs (
Now, the raised veins are almost no longer noticeable.
有効二肌のほてり、および1週間後の肌荒れ、脚のむく
み、血管の浮きが非常に
弱くなった。Effectively, the hot flashes on my skin, as well as the rough skin, swelling of my legs, and bulging of my blood vessels after one week, were significantly reduced.
やや有効−肌のほてり、および1週間後の肌荒れ、脚の
むくみ、血管の浮きがやや弱
くなった。Slightly effective - Hot flashes on the skin, rough skin after one week, swelling of the legs, and bulging of blood vessels were slightly reduced.
無効:肌のほてり、および1週間後の肌荒れ、脚のむく
み、血管の浮きは変化な
し。Ineffective: No change in skin hot flashes, rough skin, leg swelling, or bulging of blood vessels after one week.
(カミソリまけの判定基準) 著効:刺毛後のカミソリまけが著しく改善された。(Criteria for razor sharpness) Significant effect: Razor stickiness after hair pricking was significantly improved.
有効:刺毛後のカミソリまけが非常に改善された。Effective: Razor compatibility after hair pricking has been greatly improved.
やや有効:刺毛後のカミソリまけかやや改善された。Slightly effective: Slightly improved razor compatibility after hair pricking.
無効:刺毛後のカミソリまけは変化なし。Invalid: There is no change in the razor blade after hair pricking.
(判定)
0 :被試験者の著効、有効の示す割合(有効率)が8
0%以上の場合
Q : ツノ
ツノ(有効率)が50〜80%の場合
×:〃lノ
(有効率)が50%以下の場合
(以下余白)
表−2
(以下余白)
表−3
表−3から明らかなようにヒキオコシの抽出物、クロパ
ナヒキオコシの抽出物を配合したものは肌のほてり、肌
荒れ、カミソリまけ、脚のむくみ、血管の浮きの改善効
果に優れていた。(Judgment) 0: The percentage of test subjects who are markedly effective or effective (effective rate) is 8.
If it is 0% or more Q: Horn
When the horn (effective rate) is 50 to 80% ×: When the lno (effective rate) is 50% or less (blank below) Table 2 (blank below) Table 3 As is clear from Table 3, Hikiokoshi A product containing extracts of ``Kuropanahikikoshi'' and ``Kuropanahikikoshi'' was effective in improving hot flashes, rough skin, razor bumps, leg swelling, and bulging blood vessels.
し実施例1
次に実施例によって本発明をざらに詳細に説明する。尚
、本発明はこれにより限定きれるものではない。配合量
は重量%である。EXAMPLE 1 Next, the present invention will be roughly explained in detail with reference to examples. However, the present invention is not limited to this. The blending amount is in weight%.
実施例 1 化 粧 水
(1)ヒキオコシ葉エタノール抽出物 o、oos(2
)グリセリン 4.0(30,3−
ブチレングリコール 4.0(4)エタノール
7.0(5)ポリオキシエチレン
オレイルアルコール 0.5
(6)メチルパラベン 0.05(7)
クエン酸 0.01(8)クエ
ン酸ソーダ 0,1(9)香料
0.05(10)精製水
残余(製法)
精製水にクエン酸、クエン酸ソーダ、グリセリン、1.
3−ブチレングリコールを溶解する。別にエタノールに
ポリオキシエチレンオレイルアルコール、香料、メチル
パラベンおよびヒキオコシ抽出物を溶解し、これを前述
の精製水溶液に加えて可溶化し、ろ過して化粧水を得た
。Example 1 Lotion water (1) Hikiokoshi leaf ethanol extract o, oos (2
) Glycerin 4.0 (30,3-
Butylene glycol 4.0(4) Ethanol
7.0 (5) Polyoxyethylene oleyl alcohol 0.5 (6) Methyl paraben 0.05 (7)
Citric acid 0.01(8) Sodium citrate 0.1(9) Flavoring
0.05 (10) Purified water
Residue (manufacturing method) Citric acid, sodium citrate, glycerin, purified water, 1.
Dissolve 3-butylene glycol. Separately, polyoxyethylene oleyl alcohol, fragrance, methylparaben, and Hikikosi extract were dissolved in ethanol, and this was added to the above-mentioned purified aqueous solution to solubilize and filtered to obtain a lotion.
実施例 2 クリーム
(1)セトステアリルアルコール 3.5(2
)スクワラン 40.0(3)
ミツロウ 3.0(4)還元
ラノリン 5.0(5)エチルパ
ラベン 0.3(6)ポリオキシエ
チレン(20)ソルビタンモノパルミチン酸エステル
2.0(7)ステアリン酸モノグリセリド 2.
0(8)ヒキオコシ葉と茎50%エタノール抽出物およ
びクロパナヒキオコシ葉
と茎50%エタノール抽出物 1.0(9)香
料 0.03(10)1
.3−ブチレングリコール 5.0(11)
グリセリン 5.0(12)精
製水 残余(製法)
(1) (2) (3) (4) (5) (6) (
7) (8)と(9)を加熱溶解し75℃に保ったもの
を、75℃に加温した(10) (11)と(12)に
撹拌しながら加える。ホモミキサー処理し乳化粒子を細
かくした後、撹拌しながら急冷し、クリームを得た。Example 2 Cream (1) Cetostearyl alcohol 3.5 (2
) Squalane 40.0 (3)
Beeswax 3.0 (4) Reduced lanolin 5.0 (5) Ethylparaben 0.3 (6) Polyoxyethylene (20) Sorbitan monopalmitate ester
2.0(7) Stearic acid monoglyceride 2.
0(8) 50% ethanol extract of Hikiokoshi leaves and stems and 50% ethanol extract of Hikiokoshi leaves and stems 1.0(9) Fragrance 0.03(10)1
.. 3-Butylene glycol 5.0 (11)
Glycerin 5.0 (12) Purified water Residue (manufacturing method) (1) (2) (3) (4) (5) (6) (
7) Dissolve (8) and (9) by heating and keep at 75°C and add to (10), (11) and (12) heated to 75°C with stirring. After processing with a homomixer to make emulsified particles fine, the mixture was rapidly cooled while stirring to obtain cream.
実施例 3 乳 液
(1)クロバナヒキオコシの茎と葉の
エタノール抽出物 3.0(2)ステア
リン酸 1.5(3)七チルアル
コール 0.5(4)ミツロウ
2.0(5)ポリオキシエチレン
(10)
モノオレイン酸エステル 1.0
(6)グリセリンモノステアリン
酸エステル 1.0
(7)クインスシード抽出物(5χ水溶′e) 20
.0(8)プロピレングリコール 5.0
(9)エタノール 3.0(1
0)エチルパラベン 0.3(11
)ヒアルロン酸ナトリウム 0.03(12
)精製水 残余(製法)
エタノールに香料およびクロバナヒキオコシのエタノー
ル抽出物の混合物を加えて溶解する(アルコール相)。Example 3 Emulsion (1) Ethanol extract of stems and leaves of Black-and-white violet 3.0 (2) Stearic acid 1.5 (3) Heptyl alcohol 0.5 (4) Beeswax
2.0 (5) Polyoxyethylene (10) Monooleic acid ester 1.0 (6) Glycerin monostearic acid ester 1.0 (7) Quince seed extract (5χ water soluble'e) 20
.. 0(8) Propylene glycol 5.0
(9) Ethanol 3.0 (1
0) Ethylparaben 0.3 (11
) Sodium hyaluronate 0.03 (12
) Purified water Residue (manufacturing method) Add a mixture of fragrance and ethanolic extract of Black Banana oleracea to ethanol and dissolve (alcohol phase).
精製水にプロピレングリコールを加え加熱溶解して70
℃に保つ(水相)。クインスシード抽出物およびヒアル
ロン酸ナトリウムを除く他の成分を混合し、加熱溶解し
て70℃に保つ(油相)。水相に油相を加え予備乳化を
行い、ホモミキサーで均一に乳化する。これを撹拌しな
がらアルコール相とクーインスシード抽出物およびヒア
ルロン酸ナトリウムを加える。その後撹拌しながら30
℃に冷却して乳液を得た。Add propylene glycol to purified water and dissolve by heating.
Keep at °C (aqueous phase). Quince seed extract and other ingredients except sodium hyaluronate are mixed, heated and dissolved and kept at 70°C (oil phase). Pre-emulsify by adding the oil phase to the water phase and homogeneously emulsify using a homomixer. While stirring, add the alcohol phase, quinces seed extract, and sodium hyaluronate. Then, while stirring,
A milky lotion was obtained by cooling to ℃.
実施例 4 バ ッ り
(1)ヒキオコシ葉のエタノール抽出物 0.5(2)
ポリビニルアルコール 15.0(3)ポリ
エチレングリコール 3.0(4)プロピレ
ングリコール 7.0(5)エタノール
10.0(6)メチルパラベン
0.05(7)香料
0.05(8)精製水
残余(製法)
精製水にポリエチレングリコール、プロピレングリコー
ル、メチルパラベンを加え撹拌溶解する。Example 4 Batter (1) Ethanol extract of Hikiokoshi leaves 0.5 (2)
Polyvinyl alcohol 15.0 (3) Polyethylene glycol 3.0 (4) Propylene glycol 7.0 (5) Ethanol
10.0(6) Methylparaben
0.05 (7) Fragrance
0.05(8) Purified water
Residue (manufacturing method) Add polyethylene glycol, propylene glycol, and methylparaben to purified water and stir to dissolve.
次にポリビニルアルコールを加え加熱撹拌し、香料を溶
解したエタノールおよびヒキオコシ抽出物を加え撹拌溶
解してパックを得た。Next, polyvinyl alcohol was added and stirred with heating, and ethanol in which the fragrance had been dissolved and Hikikosi extract were added and dissolved with stirring to obtain a pack.
実施例 5 固形白粉
(1)タルク 85.4(
2)ステアリン酸 1.5(3)
ラノリン 5.0(4)スク
ワラン 5.0(5)ソルビタ
ンセスキ
オレイン酸エステル 2.0
(6)トリエタノールアミン 1.0(7
)ヒキオコシ全草抽出物 0.001(8)
顔料 適量(8)香料
適量(製法)
タルク、顔料をニーダ−でよくかきまぜる(粉末部)。Example 5 Solid white powder (1) Talc 85.4 (
2) Stearic acid 1.5 (3)
Lanolin 5.0 (4) Squalane 5.0 (5) Sorbitan sesquioleate 2.0 (6) Triethanolamine 1.0 (7
) Hikiokoshi whole plant extract 0.001 (8)
Pigment Appropriate amount (8) Fragrance
Appropriate amount (manufacturing method) Thoroughly stir talc and pigment in a kneader (powder part).
トリエタノールアミンを50%相当量の精製水に加え7
0℃に保つ(水相)。香料を除く他の成分を混合し、加
熱溶解して70℃に保つ(油相)。水相に油相を加えホ
モミキサーで均一に乳化し、これを粉末部に加えニーダ
−で練り合わせたあと水分を蒸発させ粉砕機で処理する
。ざらにこれをよくかきまぜながら香料を均一に噴霧し
圧縮成形する。Add triethanolamine to 50% equivalent amount of purified water7
Keep at 0°C (aqueous phase). Other ingredients except the fragrance are mixed, heated and dissolved and kept at 70°C (oil phase). The oil phase is added to the water phase and homogeneously emulsified using a homomixer, and this is added to the powder portion and kneaded using a kneader, after which water is evaporated and the mixture is processed using a pulverizer. While stirring the mixture well, spray the fragrance evenly and compression mold.
実施例 6 軟 膏
(1)ヒキオコシ葉および茎の
50Xエタノール抽出物 0.1
(2)ステアリルアルコール 18.0(3)
モクロウ 20.0(4)ポリ
オキシエチレン(10モル)モノオレイン酸エステル
0.25
(5)グリセリンモノ
ステアリン酸エステル 0.25(6)ワセリン
40.0(7)精製水
21.4(製法)
精製水を70℃に保ち(水相)。他の成分を70℃にて
混合溶解する(油相)。水相に油相を加え、ホモミキサ
ーで均一に乳化後冷却して軟膏を得た。Example 6 Ointment (1) 50X ethanol extract of Hikiokoshi leaves and stems 0.1 (2) Stearyl alcohol 18.0 (3)
Mokuro 20.0 (4) Polyoxyethylene (10 mol) monooleic acid ester
0.25 (5) Glycerin monostearate 0.25 (6) Vaseline 40.0 (7) Purified water
21.4 (Production method) Keep purified water at 70°C (aqueous phase). Other components are mixed and dissolved at 70°C (oil phase). The oil phase was added to the water phase, uniformly emulsified using a homomixer, and then cooled to obtain an ointment.
実施例1〜6より得られた化粧料は、実使用により、肌
のほてり、肌荒れ、脚のむくみ、しもやけ、血管の浮き
あるいはカミソリまけに対する効果に優れていた。When actually used, the cosmetics obtained from Examples 1 to 6 were found to have excellent effects on hot flashes, rough skin, leg swelling, chilblains, raised blood vessels, and razor burn.
Claims (1)
とする皮膚外用剤。A topical skin preparation containing an extract of a plant of the genus Yamaha of the Lamiaceae family.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60205999A JPS6267027A (en) | 1985-09-18 | 1985-09-18 | Dermal drug for external use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60205999A JPS6267027A (en) | 1985-09-18 | 1985-09-18 | Dermal drug for external use |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6267027A true JPS6267027A (en) | 1987-03-26 |
JPH0517886B2 JPH0517886B2 (en) | 1993-03-10 |
Family
ID=16516230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60205999A Granted JPS6267027A (en) | 1985-09-18 | 1985-09-18 | Dermal drug for external use |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6267027A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0987189A (en) * | 1995-09-19 | 1997-03-31 | Ichimaru Pharcos Co Ltd | Antiallergic agent containing isodon japonicus hara, paeonia suffruticosa andrews, perilla frutescens britton var. acuta kudo, and/or arunica montana linne |
JPH09165313A (en) * | 1995-12-15 | 1997-06-24 | Kao Corp | Skin preparation for external use |
US6455077B2 (en) * | 2000-03-28 | 2002-09-24 | Dabur Research Foundation | Herbal composition and method of manufacturing such composition for the management of gynecological disorders |
JP2004035425A (en) * | 2002-07-01 | 2004-02-05 | Naris Cosmetics Co Ltd | Ameliorant for dropsy |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61194030A (en) * | 1985-02-25 | 1986-08-28 | Shiseido Co Ltd | Cosmetic |
-
1985
- 1985-09-18 JP JP60205999A patent/JPS6267027A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61194030A (en) * | 1985-02-25 | 1986-08-28 | Shiseido Co Ltd | Cosmetic |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0987189A (en) * | 1995-09-19 | 1997-03-31 | Ichimaru Pharcos Co Ltd | Antiallergic agent containing isodon japonicus hara, paeonia suffruticosa andrews, perilla frutescens britton var. acuta kudo, and/or arunica montana linne |
JPH09165313A (en) * | 1995-12-15 | 1997-06-24 | Kao Corp | Skin preparation for external use |
US6455077B2 (en) * | 2000-03-28 | 2002-09-24 | Dabur Research Foundation | Herbal composition and method of manufacturing such composition for the management of gynecological disorders |
JP2004035425A (en) * | 2002-07-01 | 2004-02-05 | Naris Cosmetics Co Ltd | Ameliorant for dropsy |
Also Published As
Publication number | Publication date |
---|---|
JPH0517886B2 (en) | 1993-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2969274B2 (en) | Anti-roughening agent | |
JPH0892056A (en) | Whitening cosmetic | |
WO2006043771A1 (en) | Composition comprising extract of anemarrhena asphodeloides and aralia elata, and use thereof | |
JP2764510B2 (en) | Whitening cosmetics | |
JPS61291515A (en) | Cosmetic | |
JP2004323362A (en) | Composition comprising extract from plant of genus bidens | |
JPH09208484A (en) | Active oxygen-eliminator and composition containing the same | |
JPS6267027A (en) | Dermal drug for external use | |
JPS61263909A (en) | External remedy for skin | |
JP2501593B2 (en) | Topical agent for suppressing melanin production | |
JPH05229931A (en) | Skin-whitening cosmetic | |
JPS6251606A (en) | Dermal drug for external use | |
JPH0141121B2 (en) | ||
JPH03127714A (en) | Skin cosmetic | |
JPH0672838A (en) | Cosmetic | |
EP0348215B1 (en) | Novel cosmetic and paramedicinal compositions | |
JPH09208480A (en) | Substance p-antagonizing medicine | |
JP4052750B2 (en) | Swelling improver | |
JPH0672849A (en) | Skin color-lightening cosmetic | |
JPH0314283B2 (en) | ||
JPS62234006A (en) | External drug for skin | |
JPS61254510A (en) | External agent for skin | |
JPH04356416A (en) | Skin cosmetic | |
JP2003335651A (en) | Skin care preparation for external use | |
JP2003342181A (en) | Skin external preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |